Morgan Stanley analyst issues REDUCE recommendation for TSLA on September 14, 2026 03:18PM ET. The previous analyst recommendation was Reduce.TSLA was trading at $363.97 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 34 - Buy, 33 - Hold, 15 - Sell recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst...
Piper Sandler analyst issues OVERWEIGHT recommendation for TSLA on September 14, 2026 03:18PM ET. The previous...
Joseph Feldman from Telsey Advisory issued a price target of $75.00 for KR on 2026-09-14 14:18:45.The...
John Heinbockel from Guggenheim issued a price target of $66.00 for KR on 2026-09-14 13:33:00.The adjusted...
John Freeman from Raymond James issued a price target of $67.00 for DVN on 2026-09-14 13:25:37.The...
Joseph Feldman from Telsey Advisory issued a price target of $75.00 for KR on 2026-09-14 14:18:45.The adjusted price target was set to $75.00.At the time of the announcement, KR was...
John Heinbockel from Guggenheim issued a price target of $66.00 for KR on 2026-09-14 13:33:00.The adjusted price target was set to $66.00.At the time of the announcement, KR was trading...
John Freeman from Raymond James issued a price target of $67.00 for DVN on 2026-09-14 13:25:37.The adjusted price target was set to $67.00.At the time of the announcement, DVN was...
William Kirk from Roth Capital issued a price target of $73.00 for KR on 2026-09-14 11:42:17.The adjusted price target was set to $73.00.At the time of the announcement, KR was...
from Evercore ISI issued a price target of $70.00 for KR on 2026-09-14 11:41:55.The adjusted price target was set to $70.00.At the time of the announcement, KR was trading at...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
In recent financial filings with the Securities and Exchange Commission (SEC), several institutional investors have revealed significant changes in their stakes in Microsoft Corporation (NASDAQ: MSFT), reflecting varied strategies in...
In a significant market response on Monday, shares of major memory-chip manufacturers Micron, SanDisk, and SK Hynix experienced sharp declines amid rising investor skepticism regarding artificial intelligence (AI) spending. Micron...
In a significant development within the tech sector, both NVIDIA and Palantir Technologies have raised their financial guidance, suggesting an optimistic outlook that contrasts sharply with the recent downward trajectory...
As the equity market experiences a broad rally, signs indicate a resurgence in value investing, with market participants increasingly shifting focus away from previously dominant high-growth stocks. This shift has...
In a challenging financial landscape characterized by a broader tech selloff, Big Tech stocks, particularly Alphabet and Amazon, are surprisingly garnering investor interest. Alphabet, the parent company of Google, is...
